Leadership
Dana Ono, PhD, CEO
35+ years’ experience in life science companies and venture capital; VIMAC Ventures, Integrated Genetics (Genzyme), Enzytech (Alkermes), Damon Biotech (Abbott), Intraimmune Therapies (Amgen). Ph.D. Harvard
Qian Chen, PhD, Scientific Founder
The Michael G. Ehrlich, MD Endowed Chair in Orthopedic Research at the Warren Alpert Medical School of Brown University; Director of NIH Center of Biomedical Research Excellence. Ph.D. Tufts GSBS, Post doc Harvard Med.
Ralph Loren, JD, Legal and IP Advisor
Ralph Loren has represented pharmaceutical companies, universities and startups as partner/counsel at Lahive & Cockfield, Palmer & Dodge, Locke Lord, and others over the last 40+ years. MS Tufts, JD BU law school
Katherine Gordon, PhD, Advisor
30+ years’ experience in life science biotech and startups; Advisor to VC funds and startups, venture leader at Brown and Harvard, Apollo BioPharmaceutics, Genzyme. Ph.D. Wesleyan; Post doc Yale
Advisors
Marsha Moses, PhD
Harvard Medical School and Children’s Hospital; Member National Academy of Medicine; Expertise: cancer and vascular diseases.
Sumit Aggarwal, MBA
ELOXX Pharmaceuticals, CEO of a public, clinical stage small molecule gene therapy company; Expertise: leading, operating, and investing in pharma and biotech.
Vincent Ling, PhD
Morphocell Technologies, Chief Business Officer, Expertise: Drug delivery, helping molecules become medicines